Rating Change
Piper Sandler analysts reiterated a Overweight rating on Illumina, Inc. (NASDAQ:ILMN) on July 01, 2026.
reiterateNASDAQ:ILMN
Piper Sandler Reiterates Overweight Rating on Illumina, Inc. (ILMN)
Rating Change Piper Sandler analysts reiterated a Overweight rating on Illumina, Inc. (NASDAQ:ILMN) on July 01, 2026. Market Context Illumina, Inc.
Market Context
Illumina, Inc. operates in the Healthcare sector. The stock currently trades at $180.90 with a market capitalization of $20.8B. The stock has gained 86.7% over the past 52 weeks.
Analyst coverage from Piper Sandler provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Illumina, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Illumina, Inc.
Among the 10 most recent ratings: 5 Buy, 2 Hold, 3 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 01, 2026 | Piper Sandler | Overweight | N/A |
| Jun 29, 2026 | Guggenheim | Buy | N/A |
| Jun 26, 2026 | Bernstein | Market Perform | N/A |
| Jun 24, 2026 | Barclays | Underweight | N/A |
| Jun 10, 2026 | JP Morgan | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View ILMN Stock Page
Frequently Asked Questions
What does a Overweight rating mean for ILMN?
A Overweight rating from Piper Sandler reflects the analyst's outlook on Illumina, Inc. (NASDAQ:ILMN). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the ILMN forecast page.